Development of an electroporation-based transformation system for Moniliella megachiliensis
Bioscience, Biotechnology, and Biochemistry · 2025
DOI: 10.1093/bbb/zbaf107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, 2025. Verfasst von Taisuke Watanabe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioscience, Nihon University College of Bioresource Sciences, Kanagawa, Japan. Hauptthemen laut MEDLINE: Electroporation, Transformation, Genetic, Agaricales. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
We developed an electroporation-based transformation system for Moniliella megachiliensis, a basidiomycetous yeast producing erythritol. Using a green fluorescence protein expression vector, successful gene transfer and expression were confirmed. This is the first report of genetic transformation in this genus, providing a foundation for future genetic engineering and biotechnological applications in food and fermentation industries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioscience, Nihon University College of Bioresource Sciences, Kanagawa, Japan.
ORCID-Profile: Taisuke Watanabe
Zitieren
APA
Watanabe, T., Kimura, S., Kasumi, T., & Ogihara, J. (2025). Development of an electroporation-based transformation system for Moniliella megachiliensis. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbaf107
Vancouver
Watanabe T, Kimura S, Kasumi T, Ogihara J. Development of an electroporation-based transformation system for Moniliella megachiliensis. Bioscience, Biotechnology, and Biochemistry. 2025. doi:10.1093/bbb/zbaf107
BibTeX
@article{Watanabe2025,
author = {Watanabe, Taisuke and Kimura, Shinkuro and Kasumi, Takafumi and Ogihara, Jun},
title = {Development of an electroporation-based transformation system for Moniliella megachiliensis},
journal = {Bioscience, Biotechnology, and Biochemistry},
year = {2025},
doi = {10.1093/bbb/zbaf107}
}
EUVIMED